⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28448532 | 0.72 | — | — | |
| SCHEMBL2842852 | 0.61 | — | — | |
| SCHEMBL29290128 | 0.59 | — | — | |
| SCHEMBL18818126 | 0.58 | — | — | |
| SCHEMBL14088942 | 0.57 | — | — | |
| SCHEMBL6348802 | 0.56 | — | — | |
| SCHEMBL9037280 | 0.56 | — | — | |
| Ammonia Solution, Strong SCHEMBL28914391 | 0.56 | — | — | |
| SCHEMBL28523954 | 0.55 | — | — | |
| SCHEMBL660325 | 0.55 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114127150-A | Allophanate-based dispersants | 巴斯夫欧洲公司 | 2022-03-01 | — | — | CN | claimed |
| US-20230346951-A1 | MOLECULAR DEGRADERS OF EXTRACELLULAR PROTEINS | YALE UNIVERSITY | 2023-11-02 | — | — | US | disclosed |
| WO-2022189856-A9 | COMPOUNDS USEFUL FOR TREATING LIVER DISEASES | ABIONYX PHARMA SA (FR) | 2022-10-13 | — | — | WO | disclosed |
| CN-114127150-A | Allophanate-based dispersants | 巴斯夫欧洲公司 | 2022-03-01 | — | — | CN | disclosed |
| US-11084809-B2 | N-((HET)arylmethyl)-heteroaryl-carboxamides compounds as kallikrein inhibitors | KALVISTA PHARMACEUTICALS LIMITED (GB) | 2021-08-10 | — | — | US | disclosed |
| WO-2021034548-A1 | MITOCHONDRIAL MODULATION TO IMPROVE METABOLIC SYNDROME DURING AGING | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2021-02-25 | — | — | WO | disclosed |
| WO-2021021563-A1 | FUNCTIONALIZED LONG-CHAIN HYDROCARBON MONO- AND DI-CARBOXYLIC ACIDS USEFUL FOR THE PREVENTION OR TREATMENT OF DISEASE | ESPERVITA THERAPEUTICS, INC. (US) | 2021-02-04 | — | — | WO | disclosed |
| US-20200361923-A1 | N-((HET)Arylmethyl)-Heteroaryl-Carboxamides Compounds As Kallikrein Inhibitors | DRI UK LP (KY) | 2020-11-19 | — | — | US | disclosed |
| EP-2256120-A1 | Oxazolidinone-quinolone hybrids as antibacterial compounds | Actelion Pharmaceuticals Ltd. (CH) | 2010-12-01 | — | — | EP | disclosed |
| US-20100222302-A1 | Novel Antibacterial Compounds | ACTELION PHARMACEUTICALS LTD (CH) | 2010-09-02 | — | — | US | disclosed |
| CN-1191005-C | Surface treatment method for copper and copper alloy | MIKATSU CO LTD (JP) | 2005-02-23 | — | — | CN | disclosed |
| US-6106899-A | COATING COPPER OR COPPER ALLOY AND BONDING | MEC COMPANY LIMITED (JP) | 2000-08-22 | — | — | US | disclosed |
| CN-1211896-A | Surface treatment method for copper and copper alloy | MIKATSU CO LTD (JP) | 1999-03-24 | — | — | CN | disclosed |
| US-4565655-A | Diazabicyclononene antibacterials | ELI LILLY AND COMPANY (US) | 1986-01-21 | — | — | US | disclosed |